GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Veerhealth Care Ltd

Veerhealth Care wins repeat New York export order for Rs. 143 Lakhs

ORDERS ▲ Positive Development MEDIUM RISK
📅 Filed on BSE: 29 Apr 2026, 04:24 PM IST  ·  BSE ID: a364360b-a1d5-4b0c-a2e0-ea24bcbfc099
View Original BSE Filing (PDF)
💡
In Simple Terms
The company just won another order from a New York buyer for personal care products worth Rs. 143 Lakhs, to be delivered in 45 days.
🤖 AI Summary
  • Repeat order from New York company for personal care products valued Rs. 143 Lakhs
  • International supply contract; FOB NHava Seva terms with 45-day execution window
  • Fourth major award in 27 days; follows Rs. 5.50 Crore and Rs. 6.15 Crore domestic orders
  • Repeat order status signals client retention and validates product-market fit overseas
  • No promoter group interest; non-related party transaction at arm's length
🔢 Key Numbers — exact figures from BSE filing, not rounded
Order Value
Rs. 143 Lakhs
Order Value USD Equivalent
USD 1,51,200
Execution Timeline
45 Days
Recent Cumulative Order Pipeline (27 days)
Rs. 11.65 Crore+ (Rs. 5.50 Cr + Rs. 6.15 Cr + Rs. 143 Lakh domestic/export)
🏢 How This Affects the Company
📈
Business Impact
Repeat order from existing New York client demonstrates product-market fit and client retention in export segment. Adds to accelerating order pipeline; fourth major award in 27 days strengthens revenue visibility for FY26.
💰
Financial Impact
Rs. 143 Lakhs order adds to cash inflow pipeline. Combined with recent Rs. 5.50 Crore and Rs. 6.15 Crore domestic awards, provides near-term revenue acceleration for FY26.
⚙️
Operational Impact
45-day execution timeline requires sustained production and export logistics capacity. Repeat nature suggests supply chain and quality processes validated by client; no rework risk indicated.
⚠️
Risk Impact
Client confidentiality clause obscures buyer identity; revenue concentration on single New York repeat buyer warrants monitoring if order values scale materially.
👥 What This Means For Shareholders
✅
Action Required
No immediate action required. Monitor Q4 FY26 results disclosure for order execution status and cumulative revenue impact.
👤
Who Is Affected
All equity shareholders benefit from accelerated revenue pipeline. Order value (Rs. 143 Lakhs) is immaterial individually but significant as fourth award in 27 days, boosting FY26 visibility.
🔍
Management Signal
Repeat order indicates management successfully scaled export sales capability and product positioning in personal care segment; export strategy gaining client traction.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Q4 FY26 results (May-June 2026): verify Rs. 143 Lakhs order execution and revenue recognition
H1 FY27 order pipeline announcements: track repeat customer order frequency and export order scaling
Client concentration analysis in annual report: assess New York buyer dependency and geographic diversification
MEDIUM RISK Repeat order from undisclosed New York buyer creates revenue concentration risk if order dependency deepens without geographic diversification or order value scaling.
💡 Investor Takeaway
Veerhealth Care secured a repeat Rs. 143 Lakhs export order from New York client in personal care products, executable in 45 days. Fourth major award in 27 days; combined domestic orders (Rs. 5.50 Crore + Rs. 6.15 Crore) total Rs. 11.65 Crore, confirming sustained order momentum.
⚖️ Strengths & Concerns

✅ Positives

  • Repeat order from same New York client confirms product quality, delivery, and service standards met in prior transaction.
  • Fourth major award in 27 days (including Rs. 6.16 Crore order) signals market momentum and near-term revenue acceleration.

⚠️ Concerns

  • New York buyer identity not disclosed per confidentiality terms; revenue concentration risk if order dependency deepens.
  • Rs. 143 Lakhs order value modest relative to recent Rs. 6.15 Crore domestic order; shows export segment order sizes remain smaller.
📅 Company Track Record
Veerhealth Care secured Rs. 5.50 Crore FMCG order (76% of Q3 FY26 revenue) on 20 March 2026, followed by Rs. 6.15 Crore domestic FMCG order (17 April 2026), and Rs. 150 Lakhs New York export order (11 April 2026). Current repeat order (29 April 2026) is fourth major award in 27 days, indicating accelerating order momentum in both domestic and export segments.

Based on publicly available historical data. For context only.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again — explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.